[
    {
        "answer_full": "2023",
        "supporting_text": null,
        "country": "germany",
        "question": "period_start"
    },
    {
        "answer_full": "2030",
        "supporting_text": null,
        "country": "germany",
        "question": "period_end"
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP emphasizes the One Health approach, addressing human, animal, and environmental health.",
        "country": "germany",
        "question": 1
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP includes specific actions in the human health sector, such as preventing nosocomial infections and promoting appropriate antibiotic use.",
        "country": "germany",
        "question": 2
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP outlines strategies for animal health, including improving husbandry conditions and promoting vaccination.",
        "country": "germany",
        "question": 3
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP addresses the environmental release of antibiotics and antibiotic resistances, focusing on wastewater and soil.",
        "country": "germany",
        "question": 4
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP includes actions related to the food chain and the role of agriculture in the emergence and spread of AMR.",
        "country": "germany",
        "question": 5
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP mentions that an action plan will be published later, which will be regularly reviewed and used for reporting on implementation status.",
        "country": "germany",
        "question": 6
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP states that measurable national-level AMR targets will be defined by the end of 2023.",
        "country": "germany",
        "question": 7
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP includes the goal of reducing antibiotic use in veterinary medicine by 50% between 2018 and 2030.",
        "country": "germany",
        "question": 8
    },
    {
        "answer_full": "no",
        "supporting_text": "The document does not specify any budget allocation for the strategies or actions.",
        "country": "germany",
        "question": 9
    },
    {
        "answer_full": "no",
        "supporting_text": "The document does not include an assessment of future budget requirements.",
        "country": "germany",
        "question": 10
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP mentions the Interministerial Working Group on Antimicrobial Resistance (IMAG AMR) for cross-ministerial coordination.",
        "country": "germany",
        "question": 11
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP discusses the need for legal requirements and their enforcement to combat AMR.",
        "country": "germany",
        "question": 12
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP emphasizes the importance of knowledge dissemination and training for medical professionals.",
        "country": "germany",
        "question": 13
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP includes actions to improve public awareness about infections and appropriate antibiotic use.",
        "country": "germany",
        "question": 14
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP highlights the importance of international cooperation and collaboration with organizations like WHO and FAO.",
        "country": "germany",
        "question": 15
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP outlines the need for standardized surveillance and monitoring of antibiotic use and AMR.",
        "country": "germany",
        "question": 16
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP discusses the need for improved surveillance systems to detect and report AMR.",
        "country": "germany",
        "question": 17
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP includes prevention measures such as infection protection and control to reduce antibiotic use.",
        "country": "germany",
        "question": 18
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP emphasizes the need to align with international standards and guidelines for AMR control.",
        "country": "germany",
        "question": 19
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP discusses the need for regulations on the use and dispensing of antibiotics.",
        "country": "germany",
        "question": 20
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP includes measures to promote the rational use of antibiotics through legal frameworks.",
        "country": "germany",
        "question": 21
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP highlights the importance of research and development for new antibiotics and diagnostic tools.",
        "country": "germany",
        "question": 22
    }
]